ACE BioSciences Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

ACE BioSciences General Information


Developer of antibacterial drugs. The company is focused on developing novel vaccines for the prevention and treatment of bacterial infections, diarrhea, pneumococcal infections, cancer and streptococcus pneumonia..

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Primary Office
  • Unsbjergvej 2A
  • 5220 Odense
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACE BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Nov-2009 000.00 Completed Generating Revenue
2. Later Stage VC 19-Dec-2007 000.00 000.00 Completed Generating Revenue
1. Early Stage VC $33.7M $33.7M Completed Startup
To view ACE BioSciences’s complete valuation and funding history, request access »

ACE BioSciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BankInvest Biotech Ventures Venture Capital Minority 000 0000 000000 0
Dansk Erhvervsinvestering Venture Capital Minority 000 0000 000000 0
Heartcore Capital Venture Capital Minority 000 0000 000000 0
To view ACE BioSciences’s complete investors history, request access »